It is a fact that it's becoming increasingly more dangerous to be a woman in America. More than 76 % of adults in the United States, 194 million people, live with at least one chronic illness and women experience chronic conditions at higher rates than men do. Heart disease, cancer, and stroke are the top leading causes of death for women nationwide. Now, medical advances have made it possible to manage and treat many of these conditions, preventing them from becoming fatal, but they still remain chronic. N ...

Core Insights - Avricore Health Inc. is launching a pilot program to deliver inclisiran cholesterol-lowering injections through community pharmacies in collaboration with Barts Health NHS Trust, UCL Partners, and the British Heart Foundation [1][3][6] Group 1: Pilot Program and Funding - The pilot is supported by a £198,000 grant from the British Heart Foundation, aiming to decentralize cardiovascular therapy delivery and reduce hospital burden by shifting services to community pharmacies [3] - The initiative is part of the ELoPE-CVD program, which focuses on expanding access to preventive heart care and optimizing lipid management for high-risk patients [3] Group 2: HealthTab Integration - HealthTab™ is integrated with the Ortus-iHealth platform, allowing pharmacy-generated results to flow directly into hospital clinical systems, enhancing connectivity and data availability for clinicians and patients [4][11] - This integration positions HealthTab as a core infrastructure for NHS pharmacy-based care, moving beyond diagnostics to support therapy initiation and monitoring [7][12] Group 3: Expansion of HealthTab's Role - The pilot marks a significant expansion of HealthTab's role from primary prevention to secondary prevention, enabling community pharmacies to deliver and monitor advanced lipid-lowering therapy for patients with existing cardiovascular disease [5][10] - HealthTab is now positioned as a trusted technology partner within a high-profile cardiovascular program, validating its effectiveness in long-term lipid management pathways [7][10] Group 4: NHS Goals and Community Pharmacy Involvement - The NHS aims to prevent up to 150,000 heart attacks, strokes, and dementia cases over the next decade by improving detection and management of high-risk conditions, including high cholesterol [9] - The initiative aligns with NHS policy to enhance the role of community pharmacies in managing long-term conditions and integrating them into shared digital records [9][10] Group 5: Commitment to Quality and Performance - HealthTab is designed to meet high standards of analytical performance and reliability, supported by a comprehensive quality management program in partnership with CEQAL Inc. [15][16] - The program includes centralized monitoring of reagents and regular quality assessments to ensure accuracy and consistency of results across participating sites [16]